ISCB

DefiantDoor1201

For you as a holder, not much really changes. ILCB is now MLRG and ISCB is now MSML (switched on 5 Oct). The large/mid fund now tracks the MSCI USA index, which is about 527 stocks covering roughly 85% of the US market. So you lose the long tail of smaller names and the fund ends up a bit more concentrated in the big companies, but those dropped stocks were tiny weights anyway. The fee's still 0.03%. I'd just keep an eye on tracking difference over the next year or so. If it stays tight to the new index and the fee doesn't change, there's nothing you need to do.

NoTeslaForMe

You have VOO, so when you say "small caps," I'm hearing "everything not in VOO." That's VXF. 0.05% expense ratio, just a notch over ISCB and under IJR, but without any (mainly mid-cap) companies missing. Or, if you want to remain disproportionately in VOO, you could just get VTI to include a little VXF-equivalent at a lower expense ratio. If you want to start playing the value versus growth game or pay a premium for non-index funds (like AVUV), that's a different story.

One_Psychology_6500

ISCB has the lowest expense ratio. This is really all that matters when comparing indexed funds with large enough liquidity. They all will basically consist of the same equities at the same ratios.

CosmicSpiral

> I suggest plugging in AVUV into Portfolio Backtest since inception (Oct. 2019) and comparing to the S&P 500. You'll find it outperformed (14.8% vs 13.7% with higher volatility), so I'm really unsure which funds/benchmarks you are referring to. I typically measure small cap ETF performance from when small/micro caps hit their stagnation period (roughly November 2021 to November 2023) to the present day: the original COVID dip and jump adds too much noise to the data. Almost none of them have notably outperformed the base Russell 2000 or S&P 600, not SPSM or VTWO or ISCB. AVUV is the only small cap ETF I've seen that's surpassed its November 2021 peak.